Skip to main content

Change location

You are currently on the Austria (Deutsch) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Austria (Deutsch)
  • Careers
  • Media and News
  • Get in touch
    • Austria (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
      • X-Ray & CT
      • Contrast agents

        • Iomeron
        • Jopamiro
        • Gastromiro
      • Medical devices

        • CT Exprès
        • Protoco2l Touch
        • Empower CTA+
        • MustKit CT
      • MRI
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • Empower MR
      • CEUS
      • Contrast agents

        • Sonovue
      • Software

    • Molecular imaging
      • Cardiovascular
      • Contrast agents

        • Iomeron
        • Jopamiro
      • Medical devices

        • ACIST CVi
        • ACIST HDi
        • ACIST RXi
    • Digital health
    • Oncology
    • Cardiology
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
    • Education
    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
    • Events
    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
161 results found
Article
Bracco Announces EU Launch of AiMIFY and Expands AI Portfolio At the 2026 European Congress of Radiology (ECR), Bracco Imaging S.p.A. today announced two major milestones in its AI & Digital Health strategy: the commercial launch in the European Union of AiMIFY® and a new strategic partnership with Avicenna.AI.
Bracco Announces EU Launch of AiMIFY and Expands AI Portfolio

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Bracco Österreich GmbH
Floridsdorfer Hauptstraße 1
A-1210 Wien

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182